[When treatment has anti-doping implications: therapeutic use exemptions in primary care].

Authors

M Sarmiento-Cruz, J I Ramírez-Manent

Published in

Semergen. Volume 52. Issue 8. Pages 102818. Jul 28, 2026. Epub Jul 28, 2026.

Abstract

Therapeutic use exemptions (TUEs) allow athletes to use prohibited substances or methods when there is a justified medical indication and the criteria established by anti-doping regulations are fulfilled. Although TUEs are commonly associated with professional sport, family physicians may care for federated athletes or individuals subject to anti-doping testing at different levels of competition. In primary care, commonly prescribed treatments such as systemic glucocorticoids, β2-agonists, beta-blockers or diuretics may have regulatory implications if the substance used, dosage, route of administration, timing in relation to competition and clinical context are not adequately considered. In addition, substances of abuse, cannabinoids, and some cold remedies and decongestants may lead to unexpected adverse analytical findings. This article provides practical recommendations aimed at identifying patients at risk, using official consultation tools, adequately justifying medical indications and safely managing common situations related to TUEs in daily clinical practice. .

PMID:
42520544
Bibliographic data and abstract were imported from PubMed on 29 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.